Nutritional Support for Lactating Women and Azithromycin to Infants - Mumta Lactating Women Trial
Launched by VITAL PAKISTAN TRUST · Jun 11, 2018
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Mid-upper-arm-circumference of lactating women less than 23.0 cm, whose birth outcome should be captured within 168 hours
- • Singleton alive baby
- • Intention to stay in the catchment area for the entire duration of the trial after enrolment
- • Intention to breastfeed the child for at least 6 months
- • Voluntary written consent
- Exclusion Criteria:
- • Weight of newborn at first assessment, within 168 hours of birth is less than 1500 gm
- • Newborn with known congenital anomaly or sign of serious illness based of study physician's assessment before enrollment.
- • Lactating women has known allergies to peanut, lentils, chickpea or dairy products.
- • Lactating woman who have some serious medical illness/condition due to which she is not able to or not willing to breastfeed the child, like breast cancer, inverted nipples.
- • Previous enrolment in the same trial.
About Vital Pakistan Trust
Vital Pakistan Trust is a dedicated clinical trial sponsor committed to advancing healthcare through rigorous research and innovation. Focused on addressing pressing health challenges in Pakistan, the organization collaborates with healthcare professionals, academic institutions, and industry partners to conduct ethical and scientifically sound clinical trials. By prioritizing patient safety and data integrity, Vital Pakistan Trust aims to contribute to the development of effective medical interventions and improve health outcomes for diverse populations. Through its initiatives, the Trust strives to enhance the local research landscape and foster a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Trial Officials
Yasir Shafiq, MSc
Principal Investigator
Vital Pakistan Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials